Average Co-Inventor Count = 4.40
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi (27 from 1,451 patents)
2. Sanofi-synthelabo (7 from 152 patents)
3. Elf Sanofi (3 from 53 patents)
4. Sanofi-aventis (2 from 389 patents)
5. Societe Anonyme: Elf Sanofi (1 from 2 patents)
40 patents:
1. 7915258 - Substituted 2,5-dihydro-3H-pyrazolo[4,3-C]pyridazin-3-one derivatives, preparation thereof and therapeutic use of the same
2. 7632852 - [object Object]
3. 6710042 - Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
4. 6465489 - Ureidopiperidine derivatives as selective human NK3 receptor antagonists
5. 6294537 - Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
6. 6291672 - Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
7. 6242637 - Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present
8. 6235791 - Use of amines to produce drugs for preventing tumor cell proliferation
9. 6124316 - Compounds which are specific antagonists of the human NK3 receptor and
10. 6028082 - Human NK.sub.3 receptor-selective antagonist compounds, method for
11. 6011154 - Substituted heterocyclic compounds, method of preparing them and
12. 5977359 - Substituted heterocyclic compounds, method of preparing them and
13. 5965580 - Piperidine derivatives, process for obtaining them and pharmaceutical
14. 5942523 - Compounds which are selective antagonists of the human NK.sub.3 receptor
15. 5939411 - Piperidine derivatives process for obtaining them and pharmaceutical